Literature DB >> 8300907

Projections of GABAergic and cholinergic basal forebrain and GABAergic preoptic-anterior hypothalamic neurons to the posterior lateral hypothalamus of the rat.

I Gritti1, L Mainville, B E Jones.   

Abstract

Within the basal forebrain, gamma-aminobutyric acid (GABA)-synthesizing neurons are codistributed with acetylcholine-synthesizing neurons (Gritti et al. [1993] J. Comp. Neurol. 329:438-457), which constitute one of the major forebrain sources of subcortical afferents to the cerebral cortex. In the present study, descending projections of the GABAergic and cholinergic neurons were investigated to the lateral posterior hypothalamus (LHp) through which the medial forebrain bundle passes and where another major forebrain source of subcortical afferents is situated. Retrograde transport of cholera toxin b subunit (CT) from the LHp was combined with immunohistochemical staining for glutamic acid decarboxylase (GAD) and choline acetyl transferase (ChAT) using a sequential peroxidase-antiperoxidase (PAP) technique. A relatively large number of GAD+ neurons (estimated at approximately 6,200), which represented > 15% of the total population of GAD+ cells in the basal forebrain (estimated at approximately 39,000), were retrogradely labeled from the LHp. These cells were distributed through the basal forebrain cell groups, where ChAT+ cells are also located, including the medial septum and diagonal band nuclei, the magnocellular preoptic nucleus, and the substantia innominata, with few cells in the globus pallidus. In these same nuclei, a small number of ChAT+ cells were retrogradely labeled (estimated at approximately 800), which represented only a small percentage (< 5%) of the ChAT+ cell population in the basal forebrain (estimated at approximately 18,000). Both the GAD+ and ChAT+ LHp-projecting neurons represented a small subset of their respective populations in the basal forebrain, distinct from the magnocellular, presumed cortically projecting, basal neurons. In addition to the GAD+ cells in the basal forebrain, GAD+ cells in the adjacent preoptic and anterior hypothalamic regions were also retrogradely labeled in significant numbers (estimated at approximately 5,500) and proportion (> 20%) of the total population (estimated at approximately 30,000) from the LHp. The retrogradely labeled GAD+ neurons were distributed in continuity with those in the basal forebrain through the lateral preoptic area, medial preoptic area, bed nucleus of the stria terminals, and anterior and dorsal hypothalamic areas. Of the large number of cells that project to the LHp in the basal forebrain and preoptic-anterior hypothalamic regions (estimated at approximately 66,000), the GAD+ neurons represented a significant proportion (> 15%) and the ChAT+ neurons a very small proportion (approximately 2%). The relative magnitude of the GABAergic projection suggests that it may represent an important inhibitory influence of the descending efferent output from the basal forebrain and preoptic-anterior hypothalamic regions.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300907     DOI: 10.1002/cne.903390206

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  35 in total

1.  Discharge profiles of juxtacellularly labeled and immunohistochemically identified GABAergic basal forebrain neurons recorded in association with the electroencephalogram in anesthetized rats.

Authors:  I D Manns; A Alonso; B E Jones
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

2.  Discharge properties of juxtacellularly labeled and immunohistochemically identified cholinergic basal forebrain neurons recorded in association with the electroencephalogram in anesthetized rats.

Authors:  I D Manns; A Alonso; B E Jones
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

3.  Neurotensin-induced bursting of cholinergic basal forebrain neurons promotes gamma and theta cortical activity together with waking and paradoxical sleep.

Authors:  E G Cape; I D Manns; A Alonso; A Beaudet; B E Jones
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 4.  Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness.

Authors:  Dmitry Gerashchenko; Priyattam J Shiromani
Journal:  Mol Neurobiol       Date:  2004-02       Impact factor: 5.590

5.  Regulation of Lateral Hypothalamic Orexin Activity by Local GABAergic Neurons.

Authors:  Loris L Ferrari; Daniel Park; Lin Zhu; Matthew R Palmer; Rebecca Y Broadhurst; Elda Arrigoni
Journal:  J Neurosci       Date:  2018-01-08       Impact factor: 6.167

Review 6.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

7.  The effect of prefrontal stimulation on the firing of basal forebrain neurons in urethane anesthetized rat.

Authors:  Erika Gyengési; Laszlo Zaborszky; László Détári
Journal:  Brain Res Bull       Date:  2007-10-26       Impact factor: 4.077

Review 8.  Perinatal exposure to bisphenol A at the intersection of stress, anxiety, and depression.

Authors:  Kimberly R Wiersielis; Benjamin A Samuels; Troy A Roepke
Journal:  Neurotoxicol Teratol       Date:  2020-04-11       Impact factor: 3.763

9.  Distribution and intrinsic membrane properties of basal forebrain GABAergic and parvalbumin neurons in the mouse.

Authors:  James T McKenna; Chun Yang; Serena Franciosi; Stuart Winston; Kathleen K Abarr; Matthew S Rigby; Yuchio Yanagawa; Robert W McCarley; Ritchie E Brown
Journal:  J Comp Neurol       Date:  2013-04-15       Impact factor: 3.215

10.  Discharge profiles of identified GABAergic in comparison to cholinergic and putative glutamatergic basal forebrain neurons across the sleep-wake cycle.

Authors:  Oum Kaltoum Hassani; Maan Gee Lee; Pablo Henny; Barbara E Jones
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.